Navigation Links
Selective Marker Found to Indicate Aggressive Form of Breast Cancer

Researchers have linked a structural protein called nestin to a particularly deadly form of breast cancer, identifying a new biomarker that could lead to earlier detection and better treatment.//

In the January 15 issue of Cancer Research, researchers from Dartmouth Medical School demonstrate that nestin could represent a selective biological marker for basal epithelial breast tumors, a highly aggressive cancer with similarities to mammary stem cells, the regenerative cells believed to be the site of breast cancer initiation.

'Patients with this type of breast cancer are at high risk for recurrence,' said James DiRenzo, Ph.D., assistant professor at Dartmouth Medical School. ' Ideally, a marker like nestin would enable clinicians to monitor these patients through frequent tests of a biomarker and, in doing so, detect the cancer before it has a chance to come back.'

Basal epithelial tumors lack important molecular targets such as the estrogen receptor, progesterone receptor and Her2. This not only makes positive diagnosis difficult, say researchers, but also eliminates several important lines of therapy, such as tamoxifen or Herceptin, that work well for other breast cancer subtypes.

'Currently, there is no direct means of determining if a breast cancer is a basal epithelial tumor – doctors only know for certain once the other forms of breast cancer are ruled out,' DiRenzo said. 'This type of breast cancer is generally difficult to manage, but several important studies have shown that it is more likely than other breast cancer subtypes to respond to certain types of therapy, which highlights the need for a definitive diagnostic marker.'

The basal epithelial breast cancer subtype represents 17 to 37 percent of all breast cancers and is more common in premenopausal African American women than in other demographic groups. Among breast cancers, this subtype is known to have an early age of onset and a very sho
'"/>




Page: 1 2 3

Related medicine news :

1. Selective eating just an evolutionary trait?
2. New Study Questions Cannibalism As A Worldwide Selective Force
3. Govt to Pass Amendment to Curb Sex Selective Abortions: Ramadoss
4. Selective Marker Found to Indicate Aggressive Form of Breast Cancer
5. Wiping Out Memories Selectively, is Possible Now
6. Blood Marker Found To Predict Colon Cancer
7. Biochemical Markers Might Help Predict Heart Problems
8. Elevated Insulin Levels To Influence Levels Of Inflammatory Markers
9. Protein Markers for Identification of Brain Tumor
10. Protein Expression to Serve as Marker for Head and Neck Cancer
11. A New Marker For Type-2 Diabetes ?
Post Your Comments:
(Date:11/20/2008)...ewswire-USNewswire/ -- The National Minority Quali...al Association,s recent decision to develop a Heal... and patient advocates to join the Forum in encour...plans. , , "Physicians and lawyers -- even ...Puckrein, PhD, President and Chief Executive Offic...
(Date:11/20/2008)...ewswire/ -- Precision Therapeutics Inc., a leader,...sts, has secured $43 million,in additional fundin...of,ChemoFx(R). ChemoFx is a diagnostic test that...therapeutic regimen for cancer patients. New inve...ound and was joined by existing,investors Adams C...
(Date:11/20/2008)...ewswire/ -- Precyse Solutions, the leader in,driv...rmance through,technology and management solution...il of Pennsylvania as "Technology Company of the Y...e Kimmel Center. The Annual Gala honors the,regi...d entrepreneurs. More,than 1200 business leaders...
(Date:11/20/2008)...ewswire-USNewswire/ -- In a historic step toward a...or financing long-term services and supports, the ...nd the Consortium for Citizens with Disabilities (...reform. , , Together, the two coalitions r...rs, people with disabilities, and providers of hea...
Breaking Medicine News(10 mins):Health News:National Minority Quality Forum Applauds AMA's Health Insurer Code of Conduct 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 3Health News:Precyse Solutions Honored as 'Technology Company of the Year' 2Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 2Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 3Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 4
... the scientists at the Glasgow University, English...oxidants that offer protection against stroke, hea... as effective as an apple in keeping the doctor aw... effects by getting 12 volunteers to drink a pint ...
...ersions of High-tech laboratory tools such as comp...ed publicly. The NIH grantees have developed a sec...e MitoChip v2.0. This can for the first time seque...heir report will be published in the September iss...
...ed an important milestone in the development of st...lds first ever vaccine for cervical cancer, named ... in the cap of Professor Frazer, a scientist in Qu...ccine, who has relentlessly worked on this working...
...d by biologists from the University of California,...sponsible to pick up the ‘sour’ taste,// which is ...study, featured on the cover of the August 24 issu...each of the five basic tastes is detected by disti...
Other Medicine News:Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 2Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 3Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 4Health News:Discerning Sour Taste 2Health News:Discerning Sour Taste 3
(Date:11/20/2008)...PRNewswire/ -- Milk. It does a body good. And,now.... After years of,research, scientists at OncoNutr... milk that stimulate the body,s own production of ...News Release, go to:, http://www.prnewswire.com/mn...g new cancer therapies, the chief scientist, Dr. D...
(Date:11/20/2008)...RNewswire-FirstCall/ -- Duska Therapeutics,Inc.,...it has submitted its,pivotal Phase 3 ATPace clini...tocol Assessment (SPA) procedure with the U.S. Foo... to securing an agreement with the FDA, Duska inte...nd, placebo-controlled and randomized Phase 3,cli...
(Date:11/20/2008)...e/ -- Clinical data from a prospective,registry p...ium shows DVT,treatment with the Trellis(R) Perip... (Santa Clara, CA) successfully breaks up the bloo... This technique, called isolated pharmacomecha...kly and safely than current catheter-directed thro...
(Date:11/20/2008)... 20 The Scandinavian-based drug,d...esults of studies on its,lead antimicrobial candi...,the studies showed that the novel lytic peptido...significantly better towards killing Staphylococcu... gold standard drugs. In,addition to this it has ...
Breaking Medicine Technology:Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 1US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 2US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 3US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 4US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 5Vaccine may double survival in patients with deadly brain tumors 20841 1Vaccine may double survival in patients with deadly brain tumors 20841 2Report confirms increased risk of smoking substance abuse in bipolar adolescents 20838 1Report confirms increased risk of smoking substance abuse in bipolar adolescents 20838 2Researchers identify proteins making up mechanosensitive ion channels 20834 1Researchers identify proteins making up mechanosensitive ion channels 20834 2Researchers identify proteins making up mechanosensitive ion channels 20834 3
...ta being presented today at Digestive Disease Week... Microbia today,announced the presentation of data...ated colonic transit and improved bowel function,i...e bowel syndrome,(IBS-C). These data also showed l... of adverse events. Linaclotide is a first-in-clas...
...ings Show Compliance with Medication Instructions ...tion, Lifestyle,Management and More Healthcare Pro...NEW YORK, May 19, 2007 /PRNewswire/ -- Results of ...e Hypertension Education,Foundation (HEF) were pre...c. (ASH) Twenty-Second Annual Scientific Meeting,a...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 2Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 3Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 4Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 5Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 6Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 7
The FLO-GARD 6201 Volumetric Infusion Pump and the FLO-GARD 6301 Dual-Channel Volumetric Infusion Pump are industry standard in standard set infusion pump technology.
...Pathology and Laboratory Medicine at the Cleveland...rehensive academic medical center laboratories. Wi...0 pathologists and PhDs, our laboratories generate...ations and diagnostic consultations annually. Our ...
Histopathology Reference Laboratory provides a full range of histology services, encompassing routine and specialized grossing, processing, embedding, microtomy, routine and special staining and cove
Marquette General Health System Reference Laboratory provides a full range of testing including, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, Cytology, Anatomic Pathology, Flow Cytom
Medicine Products: